
Glynet-PM2 Tablet ER
Marketer
Zeelab Pharmacy Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glynet-PM2 Tablet ER
Glynet-PM2 Extended-Release tablets combine medications to effectively manage blood glucose. This medication, used alongside diet and exercise, enhances blood sugar control in adult type 2 diabetics by improving insulin utilization and consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Glynet-PM2 ER; taking it with food minimizes stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling doses. Overdosage risks dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may encompass nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Glynet-PM2 Tablet ER
No text provided to rephrase.
Uses of Glynet-PM2 Tablet ER
Managing type 2 diabetes
Major Benefits of Glynet-PM2 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glynet-PM2 Extended-Release Tablets should be administered with a meal.
Common Side effects of Glynet-PM2 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glynet-PM2 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glynet-PM2 Extended-Release Tablets should be administered with a meal.
How Glynet-PM2 Tablet ER works:
Glynet-PM2 Extended-Release tablets combine three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. Their synergistic action improves blood sugar management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glynet-PM2 Extended Release tablets with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Glynet-PM2 tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glynet-PM2 tablets pose a likely risk during lactation. Available human data indicate potential drug transfer to breast milk, potentially harming the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Glynet-PM2 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Glynet-PM2 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal parameters is recommended during treatment.
LiverCAUTION
Exercise caution when prescribing Glynet-PM2 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Glynet-PM2 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Glynet-PM2 Tablet ER :
Forgetting a Glynet-PM2 Tablet ER dose? Take it immediately if you remember. If your next dose is nearly due, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glynet-PM2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
